IDO1 and bladder transitional cell carcinoma: TANs upregulate the expression of indoleamine 2,3-dioxygenase 1 (IDO1) in cancer cells by secreting PGE2 in patients with urothelial bladder cancer (UBC), thereby inhibiting CD8+ T cell function (Ouyang et al., 2024b).